Published in J Biol Chem on September 03, 1999
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med (2009) 11.81
Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med (2010) 3.78
Mammalian collagen IV. Microsc Res Tech (2008) 2.56
A role for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen: structural basis for the crypticity of B cell epitopes. J Biol Chem (2008) 1.17
Murine membranous nephropathy: immunization with α3(IV) collagen fragment induces subepithelial immune complexes and FcγR-independent nephrotic syndrome. J Immunol (2012) 0.99
Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins. Clin Exp Immunol (2004) 0.99
Angiogenesis and chronic kidney disease. Fibrogenesis Tissue Repair (2010) 0.99
Identification of noncollagenous sites encoding specific interactions and quaternary assembly of alpha 3 alpha 4 alpha 5(IV) collagen: implications for Alport gene therapy. J Biol Chem (2008) 0.93
Association of epitope spreading of antiglomerular basement membrane antibodies and kidney injury. Clin J Am Soc Nephrol (2012) 0.92
Goodpasture's disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis. Curr Opin Nephrol Hypertens (2011) 0.88
Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome. Blood (2005) 0.88
Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers. J Immunol (2013) 0.84
Novel targets for immunotherapy in glomerulonephritis. Biologics (2008) 0.77
Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells. Clin Exp Nephrol (2005) 0.76
Molecular mapping of the Goodpasture's epitope for glomerulonephritis. Trans Am Clin Climatol Assoc (2005) 0.75
International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol (1999) 3.31
X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol (2000) 2.71
Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem (1988) 2.21
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]. Z Rheumatol (2012) 1.91
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods (2004) 1.78
Localization of the Goodpasture epitope to a novel chain of basement membrane collagen. J Biol Chem (1987) 1.77
Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia (1994) 1.69
Plasmid-encoded outer membrane protein YadA mediates specific binding of enteropathogenic yersiniae to various types of collagen. Infect Immun (1992) 1.68
Immunochemical analysis of cartilage proteoglycans. Antigenic determinants of substructures. Biochem J (1979) 1.61
XuvTools: free, fast and reliable stitching of large 3D datasets. J Microsc (2009) 1.59
Physical and immunochemical studies of the globular domain of type IV collagen. Cryptic properties of the Goodpasture antigen. J Biol Chem (1985) 1.50
Properties of the globular domain of type IV collagen and its relationship to the Goodpasture antigen. J Biol Chem (1985) 1.50
Separation and characterization of two populations of aggregating proteoglycans from cartilage. Biochem J (1985) 1.49
Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl(alpha 1-3)-galactose epitopes. J Exp Med (1987) 1.49
T cell recognition of carbohydrates on type II collagen. J Exp Med (1994) 1.46
Homozygosity for DNASE2 single nucleotide polymorphisms in the 5'-regulatory region is associated with rheumatoid arthritis. Ann Rheum Dis (2008) 1.45
Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Scand J Gastroenterol (1995) 1.45
Circulating autoantibodies as serological markers in the differential diagnosis of pulmonary renal syndrome. J Intern Med (1995) 1.45
Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol (1998) 1.44
A rapid and semi-quantitative method for the detection of autoantibodies by multiple spot immunoassay. J Immunol Methods (1994) 1.44
Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK) J Gastroenterol Hepatol (2000) 1.43
Outer membrane protein YadA of enteropathogenic yersiniae mediates specific binding to cellular but not plasma fibronectin. Infect Immun (1993) 1.41
Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen. Proc Natl Acad Sci U S A (1984) 1.37
Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease. Kidney Int (1999) 1.36
Isolation of the specific glomerular basement membrane antigen involved in Goodpasture syndrome. Proc Natl Acad Sci U S A (1984) 1.33
Basement membrane collagen in the kidney: regional localization of novel chains related to collagen IV. Kidney Int (1989) 1.32
Oxygen radicals as effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis Rheum (1986) 1.28
Immunochemical analysis of cartilage proteoglycans. Radioimmunoassay of the molecules and the substructures. Biochem J (1980) 1.27
Spatial quantitative analysis of fluorescently labeled nuclear structures: problems, methods, pitfalls. Chromosome Res (2008) 1.26
Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation. Oncogene (1999) 1.26
Goodpasture syndrome: molecular architecture and function of basement membrane antigen. Lab Invest (1989) 1.23
[Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis]. Z Rheumatol (2011) 1.21
Structural heterogeneity of the noncollagenous domain of basement membrane collagen. J Biol Chem (1988) 1.20
Antiglomerular basement membrane antibody: antibody specificity in different forms of glomerulonephritis. Kidney Int (1983) 1.19
Micro-Raman spectroscopic identification of bacterial cells of the genus Staphylococcus and dependence on their cultivation conditions. Analyst (2005) 1.17
Human tissue distribution of novel basement membrane collagen. Am J Pathol (1989) 1.17
Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern. Clin Exp Immunol (1994) 1.16
IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA). Nephrol Dial Transplant (1993) 1.16
Patients with IgA nephropathy have circulating anti-basement membrane antibodies reacting with structures common to collagen I, II, and IV. Proc Natl Acad Sci U S A (1986) 1.15
Assay of proteoglycan populations using agarose-polyacrylamide gel electrophoresis. Anal Biochem (1985) 1.15
Seminiferous tubule basement membrane. Composition and organization of type IV collagen chains, and the linkage of alpha3(IV) and alpha5(IV) chains. J Biol Chem (1997) 1.14
Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol (1994) 1.13
Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission. Clin Exp Immunol (2003) 1.13
Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin? Clin Exp Immunol (1997) 1.12
Strong link between the alpha 1-antitrypsin PiZ allele and Wegener's granulomatosis. J Intern Med (1994) 1.12
The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int (1995) 1.11
Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci U S A (1996) 1.10
A method for the quantification of cartilage proteoglycan structures liberated to the synovial fluid during developing degenerative joint disease. Scand J Clin Lab Invest (1985) 1.09
Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods (1996) 1.08
Preferential cellular and humoral immune reactivities to native and denatured collagen types IX and XI in a patient with fatal relapsing polychondritis. J Rheumatol (1993) 1.08
Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis. Clin Exp Immunol (2005) 1.06
Macrophages, but not dendritic cells, present collagen to T cells. Eur J Immunol (1995) 1.05
Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int (1994) 1.04
Characterization of monoclonal antibodies to proteinase-3 and application in the study of epitopes for classical anti-neutrophil cytoplasm antibodies. Exp Nephrol (1996) 1.04
Screening for anti-neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice? Clin Exp Immunol (1995) 1.03
Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Kidney Int (1998) 1.03
Evidence for susceptibility determinant(s) to psoriasis vulgaris in or near PTPN22 in German patients. J Med Genet (2005) 1.03
Interaction of enteropathogenic Yersinia enterocolitica with complex basement membranes and the extracellular matrix proteins collagen type IV, laminin-1 and -2, and nidogen/entactin. J Biol Chem (1994) 1.03
Chronic upper airway obstruction and pulmonary hypertension in Down's syndrome. Am J Dis Child (1981) 1.02
Serum IgA-fibronectin aggregates in patients with IgA nephropathy and Henoch-Schönlein purpura: diagnostic value and pathogenic implications. The Glomerular Disease Collaborative Network. Am J Kidney Dis (1991) 1.01
Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes. Nephrol Dial Transplant (1997) 1.00
Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins. Clin Exp Immunol (2004) 0.99
Characterization of monoclonal antibodies to the globular domain of collagen IV. Connect Tissue Res (1991) 0.99
Alport syndrome in southern Sweden. Clin Nephrol (2005) 0.98
Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Oncogene (1995) 0.98
Characterization of type IV collagen NC1 monomers and Goodpasture antigen in human renal basement membranes. J Lab Clin Med (1990) 0.98
[Coagulation factors in human born blisters (author's transl)]. Blut (1977) 0.98
Arthritis-related B cell epitopes in collagen II are conformation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils. J Biol Chem (1998) 0.97
Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma. J Immunol Methods (1994) 0.97
A rapid assay for circulating anti-glomerular basement membrane antibodies in Goodpasture syndrome. J Immunol Methods (1989) 0.97
Fully automated classification of HARDI in vivo data using a support vector machine. Neuroimage (2009) 0.97
Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes. J Immunol Methods (1998) 0.96
Synergistic activation of the mkp-1 gene by protein kinase A signaling and USF, but not c-Myc. FEBS Lett (2000) 0.96
Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol (1991) 0.96
Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. Proc Natl Acad Sci U S A (1988) 0.95
Serum collagenase activity in chronic liver diseases. Pathol Res Pract (1994) 0.95
Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption. Lancet (1985) 0.95
The structural organization of type IV collagen. Identification of three NC1 populations in the glomerular basement membrane. J Biol Chem (1992) 0.94
Hydroxyproline excretion in various forms of growth failure. Arch Dis Child (1973) 0.94
Determination of the Tamm and Horsfall glycoprotein in human urine. Clin Chim Acta (1977) 0.93
Classification of lactic acid bacteria with UV-resonance Raman spectroscopy. Biopolymers (2006) 0.90
Urinary excretion of beta-hexosaminidase in patients with vesico-ureteric reflux. Acta Med Scand (1982) 0.90
The prevalence and clinical significance of alpha 1-antitrypsin deficiency (PiZ) and ANCA specificities (proteinase 3, BPI) in patients with ulcerative colitis. Inflamm Bowel Dis (1999) 0.90
How and why should we detect ANCA? Clin Exp Rheumatol (2001) 0.90
What we have learned from trials of immunomodulatory agents in rheumatoid arthritis: Future directions. Drugs Today (Barc) (2003) 0.89
Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II. Cell Mol Biol Res (1994) 0.88
Immunochemical analysis of cartilage proteoglycans. Cross-reactivity of molecules isolated from different species. Biochem J (1981) 0.88
A study of autoantibodies and circulating immune complexes in mercury-exposed chloralkali workers. Int Arch Occup Environ Health (1997) 0.88
An ELISA for the detection of anti-neutrophil cytoplasm antibodies (ANCA). J Immunol Methods (1990) 0.88
Characterization of the binding region for the Yersinia enterocolitica adhesin YadA on types I and II collagen. Arthritis Rheum (1995) 0.87
Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells. Oncogene (1997) 0.87
The involvement of type IV collagen in Goodpasture's syndrome. Ann N Y Acad Sci (1985) 0.87
Novel distribution of the secretory leucocyte proteinase inhibitor in kidney. Mediators Inflamm (2001) 0.87
Complexes between proteinase 3, alpha 1-antitrypsin and proteinase 3 anti-neutrophil cytoplasm autoantibodies: a comparison between alpha 1-antitrypsin PiZ allele carriers and non-carriers with Wegener's granulomatosis. Eur J Clin Invest (1996) 0.86
Antibodies against galactosyl (alpha 1----3) galactose in connective tissue diseases. Arthritis Rheum (1991) 0.86
Upregulation of type X collagen expression in osteoarthritic cartilage. Acta Orthop Scand Suppl (1995) 0.86
Separation and chemiluminescence properties of human, canine and rat polymorphonuclear cells. J Immunol Methods (1988) 0.86